Davis; Stephen Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Davis; Stephen Thomas.The latest application filed is for "combinations of a glp1r agonist and metformin and use thereof for the treatment of type 2 diabetes and other disorders".

Company Profile

0.17.14

Davis; Stephen Thomas - Durham NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combinations of a GLP1R Agonist and Metformin and Use Thereof for the Treatment of Type 2 Diabetes and Other Disorders App 20150313908 - Mjalli; Adnan M.M. ; et al.	2015-11-05
Substituted azoanthracene derivatives and intermediates for preparation thereof Grant 9,175,003 - Mjalli , et al. November 3, 2	2015-11-03
Oxadiazoanthracene compounds for the treatment of diabetes Grant 9,120,813 - Mjalli , et al. September 1, 2	2015-09-01
Substituted Azoanthracene Derivatives and Intermediates for Preparation Thereof App 20150148539 - Mjalli; Adnan M.M. ; et al.	2015-05-28
Oxadiazoanthracene Compounds for the Treatment of Diabetes App 20150087640 - Mjalli; Adnan M.M. ; et al.	2015-03-26
Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof Grant 8,987,295 - Mjalli , et al. March 24, 2	2015-03-24
Oxadiazoanthracene compounds for the treatment of diabetes Grant 8,933,222 - Mjalli , et al. January 13, 2	2015-01-13
Oxadiazoanthracene Compounds for the Treatment of Diabetes App 20140187769 - Mjalli; Adnan M.M. ; et al.	2014-07-03
Oxadiazoanthracene compounds for the treatment of diabetes Grant 8,703,766 - Mjalli , et al. April 22, 2	2014-04-22
Oxadiazoanthracene Compounds For The Treatment Of Diabetes App 20130317015 - Mjalli; Adnan M.M. ; et al.	2013-11-28
Oxadiazoanthracene compounds for the treatment of diabetes Grant 8,524,708 - Mjalli , et al. September 3, 2	2013-09-03
Substituted Azoanthracene Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof App 20130096150 - Mjalli; Adnan M.M. ; et al.	2013-04-18
Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof Grant 8,383,644 - Mjalli , et al. February 26, 2	2013-02-26
Substituted Azoanthracene Derivatives, Pharmaceutical Compositions, And Methods Of Use Thereof App 20110160198 - Mjalli; Adnan M.M. ; et al.	2011-06-30
Oxadiazoanthracene compounds for the treatment of diabetes Grant 7,906,507 - Mjalli , et al. March 15, 2	2011-03-15
Oxadiazoanthracene Compounds For The Treatment Of Diabetes App 20110039837 - Mjalli; Adnan M.M. ; et al.	2011-02-17
Oxadiazoanthracene Compounds For The Treatment Of Diabetes App 20100324033 - Mjalli; Adnan M.M. ; et al.	2010-12-23
Oxadiazoanthracene compounds for the treatment of diabetes Grant 7,790,714 - Mjalli , et al. September 7, 2	2010-09-07
Oxadiazoanthracene Compounds For The Treatment Of Diabetes App 20100197677 - Mjalli; Adnan M.M. ; et al.	2010-08-05
Oxadiazoanthracene compounds for the treatment of diabetes Grant 7,727,983 - Mjalli , et al. June 1, 2	2010-06-01
Oxadiazoanthracene Compounds For The Treatment Of Diabetes App 20090306063 - Mjalli; Adnan M.M. ; et al.	2009-12-10
Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects Grant 7,105,529 - Davis , et al. September 12, 2	2006-09-12
Method for reducing the severity of side effects of chemotherapy and/or radiation therapy Grant 6,620,818 - Davis September 16, 2	2003-09-16
Cancer treatment method App 20030171306 - Davis, Stephen Thomas ; et al.	2003-09-11
Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects App 20030069430 - Davis, Stephen Thomas ; et al.	2003-04-10
Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors Grant 6,541,503 - Davis , et al. April 1, 2	2003-04-01
Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors App 20030004351 - Davis, Stephen Thomas ; et al.	2003-01-02
Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors Grant 6,387,919 - Davis , et al. May 14, 2	2002-05-14
Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors Grant 6,369,086 - Davis , et al. April 9, 2	2002-04-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.